Spironolactone blocks the mineralocorticoid receptor in the distal nephron, reducing potassium excretion
If youre seeing positive resultssuch as a steady reduction in weight, improved appetite control, and better blood sugar managementyou may be encouraged to continue treatment for as long as these benefits persist
In addition, our approach is constrained by the limited number of genetic proxies available to GLP-1RAs, which would preclude further sensitivity analyses for horizontal pleiotropy [39]
Upper limb spasticity : Muscle stiffness in the arms, elbows, or hands, often after a stroke or in patients with conditions like cerebral palsy or multiple sclerosis
While both medications contain the same active ingredient (semaglutide) and serve a similar purpose, they differ significantly in their administration and dosage forms